Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
8
NMPA:8
Drug Approvals
Lodoxamide Tromethamine Eye Drops
- Product Name
- 洛度沙胺氨丁三醇滴眼液
- Approval Number
- 国药准字H20249725
- Approval Date
- Dec 10, 2024
NMPA
Flurbiprofen Sodium Eye Drops
- Product Name
- 氟比洛芬钠滴眼液
- Approval Number
- 国药准字H20249614
- Approval Date
- Dec 1, 2024
NMPA
Bromfenac Sodium Eye Drops
- Product Name
- 溴芬酸钠滴眼液
- Approval Number
- 国药准字H20247205
- Approval Date
- Sep 10, 2024
NMPA
Azelastine Hydrochloride Eye Drops
- Product Name
- 盐酸氮䓬斯汀滴眼液
- Approval Number
- 国药准字H20244119
- Approval Date
- Jun 25, 2024
NMPA
Bromfenac Sodium Eye Drops
- Product Name
- 溴芬酸钠滴眼液
- Approval Number
- 国药准字H20213554
- Approval Date
- Jun 29, 2021
NMPA
Ipratropium Bromide Solution for Inhalation
- Product Name
- 吸入用异丙托溴铵溶液
- Approval Number
- 国药准字H20213486
- Approval Date
- Jun 16, 2021
NMPA
Ipratropium Bromide Solution for Inhalation
- Product Name
- 吸入用异丙托溴铵溶液
- Approval Number
- 国药准字H20213485
- Approval Date
- Jun 16, 2021
NMPA
Clinical Trials
No trials found
News
No news found